Clip procedure for leaking tricuspid valve in high-risk patients
Part of Heart & circulation clinical trials.
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 60 or older.
- You have moderate to severe tricuspid valve leakage (at least “3+”).
- A heart team must judge you as high surgical risk (STS score over 6%) and believe this repair may help.
- Your left heart pumping strength is okay (LVEF 40% or higher).
- Your lung artery pressure is not too high (pulmonary artery systolic pressure below 55 mmHg).
- You have no prior tricuspid valve repair/annuloplasty ring, no recent major heart/stroke events, and no active serious infections or heart blood clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a heart procedure called K-Clip TM helps people with severe “secondary” tricuspid valve leakage who are at high risk for open-heart surgery. It aims to improve symptoms and valve function using a less-invasive, catheter-based repair.
This study tests a device called TriClip to repair a leaky tricuspid valve in the heart. If the leak is reduced, you may have less shortness of breath and feel more energetic.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This study is testing whether the TriClip device helps people with severe tricuspid regurgitation (a leaky heart valve) feel better. It compares people who received the TriClip to those who didn't get the procedure.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.